Q4 2021 Holdings
Filed 2022-02-14 | 36 holdings | $44.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $16.0M | 350,000 | 35.8% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $12.2M | 200,000 | 27.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $11.6M | 800,000 | 26.1% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $2.6M | 668,907 | 5.8% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $1.8M | 472,433 | 4.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $49.3K | 530,670 | 0.1% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $32.0K | 1,750,000 | 0.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $29.7K | 950,000 | 0.1% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $24.8K | 800,000 | 0.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $20.6K | 592,250 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $18.7K | 85,000 | 0.0% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $17.0K | 864,300 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $16.5K | 300,000 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $16.2K | 717,320 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $16.1K | 1,000,000 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $13.4K | 1,400,000 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $13.3K | 5,000,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $13.1K | 145,405 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $11.9K | 500,000 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $11.9K | 500,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $10.9K | 500,526 | 0.0% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $10.6K | 444,443 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $10.0K | 845,000 | 0.0% |
| Passage BIO Inc | COM | 702712100 | $9.6K | 1,518,095 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $9.0K | 1,121,122 | 0.0% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $8.3K | 873,424 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $6.4K | 390,041 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $6.3K | 536,738 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $5.9K | 1,550,000 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $5.5K | 411,937 | 0.0% |
| Magenta Therapeutics Inc | COM | 55910K108 | $5.2K | 1,170,000 | 0.0% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $4.4K | 400,000 | 0.0% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $4.3K | 910,251 | 0.0% |
| Nektar Therapeutics(NKTREUR)Call | COM | 640268108 | $2.8K | 203,900 | 0.0% |
| Rafael Hldgs Inc(RFL) | COM CL B | 75062E106 | $1.5K | 285,714 | 0.0% |
| Point Biopharma Global Inc | COM | 730541109 | $1.1K | 190,520 | 0.0% |